Literature DB >> 18640567

The E. Donnall Thomas lecture: normal and neoplastic stem cells.

Irving L Weissman1.   

Abstract

Dr. Irving Weissman was the honored E. Donnall Thomas lecturer at the Tandem BMT Meetings, held on February 10, 2007, at Keystone, Colorado. Dr. Weissman has been a major player, and has provided us with enormous insight into many areas of biology, dating back to his high school days in Montana. He led an enormously productive career at Stanford University where he has taught us many lessons involving our understanding of lymphocyte homing, stem cell biology, both of the hematopoietic system and other types of stem cells, and also now, about cancer stem cells. Dr. Weissman has made enormous contributions to this burgeoning field that has provided us new insights and new opportunities for treatment strategies. In addition to a very productive laboratory career, he is also currently the director of both the Stem Cell Institute, as well as the Cancer Center at Stanford University. The following text is a modified transcribed version of the presentation made by Dr. Weissman.

Entities:  

Mesh:

Year:  2008        PMID: 18640567      PMCID: PMC2821216          DOI: 10.1016/j.bbmt.2008.05.003

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  39 in total

1.  Evidence for stem cells in the peripheral blood of mice.

Authors:  J W GOODMAN; G S HODGSON
Journal:  Blood       Date:  1962-06       Impact factor: 22.113

2.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

3.  A common precursor for primitive erythropoiesis and definitive haematopoiesis.

Authors:  M Kennedy; M Firpo; K Choi; C Wall; S Robertson; N Kabrun; G Keller
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

4.  Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer.

Authors:  R S Negrin; K Atkinson; T Leemhuis; E Hanania; C Juttner; K Tierney; W W Hu; L J Johnston; J A Shizurn; K E Stockerl-Goldstein; K G Blume; I L Weissman; S Bower; R Baynes; R Dansey; C Karanes; W Peters; J Klein
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

5.  Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells.

Authors:  Stephanie Smith-Berdan; Daphne Gille; Irving L Weissman; Julie L Christensen
Journal:  Blood       Date:  2007-04-13       Impact factor: 22.113

6.  Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients.

Authors:  U Dührsen; J L Villeval; J Boyd; G Kannourakis; G Morstyn; D Metcalf
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

7.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

8.  Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.

Authors:  E Passegué; W Jochum; M Schorpp-Kistner; U Möhle-Steinlein; E F Wagner
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

9.  Increase in circulating stem cells following chemotherapy in man.

Authors:  C M Richman; R S Weiner; R A Yankee
Journal:  Blood       Date:  1976-06       Impact factor: 22.113

10.  Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice.

Authors:  Georg F Beilhack; Yolanda C Scheffold; Irving L Weissman; Cariel Taylor; Libuse Jerabek; Matthew J Burge; Marilyn A Masek; Judith A Shizuru
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.